$21.8M Revenue For NASDAQ-Listed Psychedelics Ancillary Company Societal CDMO's Q2 2023

By Lara Goldstein

Societal CDMO Inc. (NASDAQ: SCTL ), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for small molecule therapeutics, reported financial results for the three and six months ended Ju

You are viewing a robot-friendly page.Click hereto reload in standard format.